Form 4: Collegium Pharmaceutical EVP Colleen Tupper Reports Stock Sale

Colleen Tupper, EVP & Chief Financial Officer of Collegium Pharmaceutical, sold 10,445 shares of common stock at a weighted average price of $30.006.

Summary

• Colleen Tupper, the EVP & Chief Financial Officer of Collegium Pharmaceutical, reported a transaction involving the company's common stock.
• On March 11, 2025, Ms. Tupper sold 10,445 shares of common stock.
• The sale was executed at a weighted average price of $30.006 per share.
• The total number of shares beneficially owned following the reported transaction is 165,246.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 14, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of an insider stock sale under a pre-arranged trading plan. There's no indication of positive or negative implications for the company.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to sell shares for personal financial management, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on inside information.

Stakeholder Impact

• The stock sale by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider information.

Key Dates